SCHEMBL2018124

SCHEMBL2018124

Cc1sc2nc(C(=O)N(C)C(CCNC(=O)c3cccn3C)Cc3ccccc3)cn2c1C

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.55
HCRTR2 O43614 2/20 0.55
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
OPRM1 P35372 1/20 0.35
PADI4 Q9UM07 3/20 0.35
HPGD P15428 2/20 0.34
POLB P06746 1/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC6 Q9UBN7 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015686 0.85 HCRTR1 (0.55) HCRTR1HCRTR2RAB9ANPC1OPRM1
SCHEMBL2017397 0.84 HCRTR1 (0.57) HCRTR1HCRTR2RAB9ANPC1OPRM1
SCHEMBL2015404 0.82 HCRTR1 (0.57) HCRTR1HCRTR2RAB9ANPC1OPRM1
SCHEMBL2010539 0.82 HCRTR1 (0.63) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2014309 0.82 HCRTR1 (0.57) HCRTR1HCRTR2RAB9ANPC1OPRM1
SCHEMBL2014229 0.82 HCRTR1 (0.58) HCRTR1HCRTR2RAB9ANPC1OPRM1
SCHEMBL2013183 0.81 HCRTR1 (0.61) HCRTR1HCRTR2RAB9ANPC1HRH3
SCHEMBL2012310 0.80 HCRTR1 (0.67) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2013416 0.80 HCRTR1 (0.60) HCRTR1HCRTR2RAB9ANPC1OPRM1
SCHEMBL2013001 0.80 HCRTR1 (0.56) HCRTR1HCRTR2RAB9ANPC1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed